| 000 | 01203nam a2200193Ia 4500 | ||
|---|---|---|---|
| 008 | 140223b2003 xxu||||| |||| 00| 0 eng d | ||
| 020 |
_a9781560327219 _c0.00 |
||
| 082 |
_a660.60289 _bTHO |
||
| 245 | _aBiotechnology and Safety Assessment | ||
| 250 | _a2nd ed | ||
| 260 |
_aNew York _bTaylor & Francis _c2003 |
||
| 300 | _a333p | ||
| 500 | _aGenomic Information: Frontiers of Toxicology antisense Therapeutics Safety evaluation for New varieties of Food Crops Developed through Biotechnology Therapeutic Manipulation of Cytokines Triplex & Ribozyme Technology in Gene Repression Food Allergens: Implications for Biotechnology The Pharmacokinetics & Toxicity of Phosphorothioate Oligonucleotides Biotechnology inAgriculture & tje Environment : Benefits & Risks Biotchnology & Risk Safety Assessment of Insect-Protected Corn Pharmacology of Recombinan Proteins Biotechnology: Therapeutic & Nutritional Products Clinical Toxicity of Interferons | ||
| 600 |
_aBiotechnology _916135 |
||
| 700 |
_aThomas, John A. _eEditor _916136 |
||
| 942 |
_2ddc _cLB _k660.60289 _mTHO |
||
| 995 |
_aPharmacy Lending _eP00264 _j660.60289 _yP00264 |
||
| 995 |
_aPharmacy Lending _eP00402 _j660.60289 _yP00402 |
||
| 999 |
_c11344 _d11344 |
||